- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: PBTZ169 - 160 mg
Total 13704 results
-
Hospices Civils de LyonGlaxoSmithKlineRecruiting
-
Novartis PharmaceuticalsCompletedHypertension | Overweight | Left Ventricular HypertrophyUnited States, Finland, Sweden, Germany, Italy, Spain, Argentina, Colombia, Russian Federation
-
Kowa Research Institute, Inc.CompletedHyperlipidemiaUnited States
-
Janssen Research & Development, LLCCompleted
-
Antev Ltd.Completed
-
EMSWithdrawnHypertension | Dyslipidemia
-
NeuroBo Pharmaceuticals Inc.CompletedHypercholesterolemia | Hypertriglyceridemia
-
Galapagos NVCompletedCystic FibrosisSpain, United Kingdom, United States, Netherlands, Belgium, Serbia
-
GlaxoSmithKlineTerminatedSystemic Lupus ErythematosusEstonia, Germany, South Africa, Peru, Sweden, France, Korea, Republic of, Hong Kong, Spain, Romania, Czechia, Argentina, Chile, Hungary, Greece, Poland
-
Novartis PharmaceuticalsCompletedHypertensionUnited States, Belgium, Hungary, Turkey, Guatemala, Slovakia, Germany, Puerto Rico, Poland
-
Vifor (International) Inc.Labcorp Drug Development IncWithdrawnBeta-ThalassemiaUnited States, Bulgaria, Israel
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2Germany
-
Hospital General Universitario ElcheUnknown
-
National Institute of Allergy and Infectious Diseases...AbbVieActive, not recruitingHIV-1-infectionUnited States
-
Cara Therapeutics, Inc.CompletedPruritus | Atopic DermatitisUnited States, Canada
-
Bandim Health ProjectCompletedMalaria | EffectivenessGuinea-Bissau
-
Valenta Pharm JSCCompletedHealthyRussian Federation
-
PfizerCompleted
-
Galapagos NVCompletedHealthyUnited Kingdom
-
Fondazione OncotechNot yet recruiting
-
EMD SeronoTerminatedLupus Erythematosus, SystemicUnited States, Korea, Republic of, Bulgaria, Argentina, Mexico, Italy, Spain, Philippines, Germany, Czechia, Chile, Poland, Peru, United Kingdom, South Africa, Brazil, Russian Federation
-
BiocadCompletedSeropositive RARussian Federation, Belarus
-
Adynxx, Inc.National Institute on Drug Abuse (NIDA)Withdrawn
-
National and Kapodistrian University of AthensRecruitingChronic Rhinosinusitis With Nasal Polyps | Chronic Rhinosinusitis Without Nasal Polyps | Severe Eosinophilic AsthmaGreece
-
University of MemphisDeerland Probiotics and EnzymesCompletedImmunity | Smoking, CigaretteUnited States
-
AbbVieCompleted
-
AstraZenecaCompletedMajor Depressive DisorderUnited Kingdom
-
Stayble TherapeuticsActive, not recruitingDiscogenic PainSpain, Russian Federation, Netherlands
-
City Clinical Hospital No.52 of Moscow Healthcare...Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry...Active, not recruitingCoronavirus InfectionsRussian Federation
-
Ixchelsis LimitedCompleted
-
Dexa Medica GroupCompleted
-
Intermountain Health Care, Inc.Merck Sharp & Dohme LLC; AbbottCompletedType II Diabetes Mellitus | Mixed DyslipidemiaUnited States
-
Xspray Pharma ABQPS Bioserve India Pvt LimitedCompleted
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingSmall Cell Lung Carcinoma | Small-cell Lung CancerUnited States
-
KalVista Pharmaceuticals, Ltd.Not yet recruiting
-
Lpath, Inc.CompletedHealthy SubjectsUnited States
-
NovartisCompletedChronic Heart FailureUnited States
-
Regeneron PharmaceuticalsCompletedIntercritical GoutUnited States, Canada
-
Cerevel Therapeutics, LLCRecruitingApathy in DementiaUnited States, Canada
-
Mustafa Kemal UniversityNovartis PharmaceuticalsCompletedHypertension | Left Ventricular HypertrophyTurkey
-
Sprout Pharmaceuticals, IncTerminatedDepression | Sexual Dysfunctions, PsychologicalUnited States
-
Andrew J. Armstrong, MDCompletedProstate CancerUnited States
-
Merck Sharp & Dohme LLCCompleted
-
University of CalgaryNot yet recruitingChronic Migraine
-
Janssen Research & Development, LLCCompletedDepressive Disorder, MajorGermany, Netherlands
-
Vanderbilt University Medical CenterCompletedHigh Blood PressureUnited States
-
Janssen Pharmaceutical K.K.TerminatedDermatitis, AtopicJapan
-
Yuhan CorporationCompleted
-
Johnson & Johnson Pharmaceutical Research & Development...Completed